Department of Primary Care and Public Health, Imperial College London Charing Cross Campus, London W6 8RP, UK.
J R Soc Med. 2010 Jun;103(6):239-50. doi: 10.1258/jrsm.2010.100113.
Adverse drug reactions (ADR) are an important cause of morbidity and mortality. We analysed trends in hospital admissions associated with ADRs in English hospitals between 1999 and 2008.
Data from the Hospital Episode Statistics database were examined for all English hospital admissions (1999-2008) with a primary or secondary diagnosis of an ADR recorded.
All NHS (public) hospitals in England.
The number of admissions and in-hospital mortality rate with a primary (codes including 'adverse drug reaction', 'drug-induced', 'due to drug', 'due to medicament' or 'drug allergy') or secondary diagnosis of ADR (ICD-10 Y40-59) were obtained and analysed. Further analysis for the year 2008-2009 was performed with regard to age, gender, proportion aged >65 yrs and total bed-days.
Between 1999 and 2008, there were 557,978 ADR-associated admissions, representing 0.9% of total hospital admissions. Over this period the annual number of ADRs increased by 76.8% (from 42,453 to 75,076), and in-hospital mortality rate increased by 10% (from 4.3% to 4.7%). In 2008, there were 6,830,067 emergency admissions of which 75,076 (1.1%) were drug-related. Systemic agents were most commonly implicated (19.2%), followed by analgesics (13.3%) and cardiovascular drugs (12.9%).There has been a near two-fold increase in nephropathy and cardiovascular consequences secondary to drugs and a 6.8% fall in mental and behavioural disorders due to drugs. Conclusions ADRs have a major impact on public health. Our data suggest the number of ADR admissions has increased at a greater rate than the increase in total hospital admissions; some of this may be due to improved diagnostic coding. However, in-hospital mortality due to ADR admissions also increased during the period. Our findings should prompt policymakers to implement further measures to reduce ADR incidence and their associated in-hospital mortality, and methods to improve the recording of ADRs.
药物不良反应(ADR)是发病率和死亡率的重要原因。我们分析了 1999 年至 2008 年期间英国医院因 ADR 住院的趋势。
对 1999-2008 年期间因 ADR 而被记录为主要或次要诊断的所有英国医院住院患者(共 1999-2008 年)的医院入院统计数据库进行了检查。
英格兰所有国民保健服务(公共)医院。
获得并分析了因 ADR 而被记录为主要诊断(包括“药物不良反应”、“药物诱发”、“药物引起”、“药物所致”或“药物过敏”的代码)或次要诊断(ICD-10 Y40-59)的住院人数和院内死亡率。还对 2008-2009 年的年龄、性别、>65 岁的比例和总住院天数进行了进一步分析。
1999 年至 2008 年间,共有 557978 例与 ADR 相关的住院治疗,占总住院人数的 0.9%。在此期间,ADR 的年发生数增加了 76.8%(从 42453 例增加到 75076 例),院内死亡率增加了 10%(从 4.3%增加到 4.7%)。2008 年,共有 6830067 例急诊入院,其中 75076 例(1.1%)与药物有关。最常见的是全身性药物(19.2%),其次是镇痛药(13.3%)和心血管药物(12.9%)。由于药物引起的肾病和心血管后果增加了近两倍,而由于药物引起的精神和行为障碍减少了 6.8%。结论:药物不良反应对公众健康有重大影响。我们的数据表明,ADR 入院人数的增长速度快于总住院人数的增长速度;部分原因可能是诊断编码的改进。然而,在此期间,因 ADR 入院导致的院内死亡率也有所增加。我们的研究结果应促使政策制定者采取进一步措施,降低 ADR 的发生率及其相关的院内死亡率,并改进 ADR 记录方法。